Regenxbio Inc (RGNX)
7.77
-0.09
(-1.14%)
USD |
NASDAQ |
Jan 03, 16:00
7.77
0.00 (0.00%)
After-Hours: 20:00
Regenxbio Research and Development Expense (Annual): 232.27M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Catalyst Pharmaceuticals Inc | 93.15M |
| Vertex Pharmaceuticals Inc | 3.69B |
| Sarepta Therapeutics Inc | 877.39M |
| Edgewise Therapeutics Inc | 90.90M |
| Entrada Therapeutics Inc | 99.88M |